Sitagliptin

Sitagliptin is a DPP‑4 inhibitor with modest HbA1c reduction and cardiovascular neutrality; it has no demonstrated heart failure outcome benefit. DPP-4 inhibitors may in fact exacerbate heart failure symptoms through oedema worsening. This is not the best drug for Mr. Green.

Please go back and re-consider. 

  • Setting up the reaction [undo]
  • Areas B, C and D are contaminated. [undo]
  • Sunt necesare mostre mici și informații structurale interne [undo]
  • Prophase, prometaphase, metaphase, anaphase, telophase [undo]
  • Εξοπλισμός εργαστηριακής ασφάλειας [undo]
  • 0% probability [undo]
  • Images from TEM and SEM [undo]
  • Quantification of bacterial load: Serial dilutions [undo]
  • Τα ούρα του ασθενούς περιέχουν γλυκόζη [undo]
  • Biopsy Results [undo]
  • Results: Effect of pH on amylase activity [undo]
  • Ignore the warning signs. [undo]
  • Node 15: Discuss the importance of feedback [undo]
  • To enhance the binding affinity of restriction endonucleases to non-specific sequences [undo]
  • Încărcarea bacteriană [undo]
  • Απευαισθητοποίηση στη μέλισσα και χορήγηση αυτοενέσιμης αδρεναλίνης [undo]
  • ISOLATION OF DNA AND POLYMERASE CHAIN REACTION (PCR) [undo]
  • Propose LLMc to Andreas [undo]
  • Rezultate RFLP [undo]
  • Λάβετε επιπλέον ιστορικό [undo]
  • Ο εθελοντής στην είσοδο θέλει να διώξει τον κόσμο που περιμένει. [undo]
  • Tipuri de microscopie electronică [undo]
  • Definition 1 [undo]
  • The reason [undo]
  • Epilogue [undo]
  • Pantoprazole [undo]
  • Epilogue [undo]
  • pH 3.0 [undo]
  • Sitagliptin [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21101
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway